Introduction
Urinary bladder paragangliomas are rare chromaffin tissue tumors (tumors of chromaffin cells origin that secrete hormones like norepinephrine, epinephrine, and dopamine) originating from the bladder wall's sympathetic innervations. They are typically identifiable by their distinctive presentation of post-micturition syncope (fainting after passing urine) and hypertensive (increased blood pressure) crises due to their functional nature. However, on occasion, they do not present with any symptoms, which can be dangerous since they may not receive the appropriate care before surgery. Hence, timely diagnosis is important.
What Is Paraganglioma?
Paragangliomas are classified as noncancerous growths and originate from chromaffin cells (these are neuroendocrine cells that secrete dopamine, norepinephrine, and epinephrine). A few of these can potentially develop into malignancies and spread to other body areas. These tumors, also known as paragangliomas, can develop in a variety of sites outside the adrenal glands. These can develop in a variety of places other than the adrenal glands.
Paragangliomas are uncommon tumors that can appear at any age, although they are typically discovered in adults between the ages of 30 and 50. Although most paragangliomas have no known etiology, certain cases have been connected to hereditary gene changes passed down from parents to their offspring.
People with paraganglioma cells may secrete catecholamines (adrenal gland hormones) such as adrenaline, which can cause periods of high blood pressure, fast heartbeat, sweating, migraines, and tremors. The release of hormones into the bloodstream, particularly adrenaline, which is well-known for its function in the body's fight-or-flight response, is frequently reflected in these symptoms.
What Is Paraganglioma of the Urinary Bladder?
Urinary bladder paraganglioma develops from the paraganglion cells in the bladder. Like paragangliomas elsewhere in the body, these tumors originate from certain bladder wall ganglion cells. They can afflict people of all ages and constitute a very tiny portion of bladder tumors.
While it is uncommon, paragangliomas in the bladder have occasionally been connected to urothelial cancer and neurofibromatosis. Up to 25 percent of instances that appear to be random may be related to an inherited condition. Hence, it is advised that patients get tested genetically. Understanding any possible genetic predisposition can be essential for managing the condition appropriately and realizing any possible effects on family members.
What Are the Symptoms of Paraganglioma of the Urinary Bladder?
The urinary bladder's non-functional paraganglioma is asymptomatic and exhibits no symptoms.
Only the functional paraganglioma of the urinary bladder shows the clinical manifestations. Usually, the patient has hypertensive crises (sudden and severe increase in blood pressure), which might be accompanied by perspiration (sweating), palpitations (increased heart rate), headaches, and hot flashes. Syncope (fainting) and hypotension (low blood pressure) following micturition (urinating) are two more frequent presentations. Sexual activity, ejaculation, defecation, excessive distention of the bladder, micturition, and bladder instrumentation are the main causes of these crises. Other symptoms include hematuria (presence of blood in the urine) and persistent increase in blood pressure. It is because of catecholamine secretion by the tumor cells.
What Are the Diagnostic Tests for Paraganglioma of the Urinary Bladder?
-
Imaging Techniques: Magnetic resonance imaging (MRI) and computed tomography (CT) scans are useful for identifying primary cancers and their metastases. But when identifying pheochromocytomas, a scan with 131 Iodine metaiodobenzylguanidine (MIBG) shows remarkable sensitivity and specificity.
-
Paraganglioma and Functional Imaging: For paraganglioma, it is very helpful to use functional imaging to target the route involved in catecholamine production, storage, and secretion. This becomes particularly important after surgery or if metastases are found.
-
Functional Assessments: For symptomatic patients, assessing plasma and urine catecholamine levels is crucial during the initial examination and follow-up. Plasma metanephrines (pheochromocytoma markers produced by catechol-o-methyltransferase in tumors) are considered more sensitive and specific indicators than urinary metanephrines for these lesions.
What Is the Differential Diagnosis of Paraganglioma of the Urinary Bladder?
Urinary bladder paragangliomas generally have a nest-like pattern and can mimic high-grade urothelial cancer. Carcinoid tumors and melanoma may also be included in the differential diagnosis. It is crucial to distinguish between these diagnoses by using immunohistochemical staining.
-
In most cases, cytokeratin positivity is seen in urothelial carcinoma and carcinoid.
-
Melanoma cells typically show positive for the S100, HMB45, and Melan A stains.
What Is the Treatment for Paraganglioma of the Urinary Bladder?
-
Surgery
-
Surgical removal with the goal of total excision is the main treatment for bladder paragangliomas. Given that these tumors frequently penetrate deeply into the bladder muscle, a partial cystectomy, which involves the removal of a portion of the bladder, is preferable to a transurethral (any procedure carried via the urethra) resection if identified early.
-
Although there is a considerable risk that these tumors will recur following surgery, this does not always indicate that they are malignant. Recurrence is not unusual, and it is not always a sign of cancer.
-
When a tumor is big or has spread to lymph nodes, a total cystectomy (the removal of the entire bladder) may be required, especially when the bladder cannot be saved. This is only utilized in more serious situations, though.
-
-
Chemotherapy or Radiation Therapy - Chemotherapy and radiation therapy are not effective treatments for bladder paragangliomas. These treatments have not been particularly successful in treating this kind of tumor, despite a few instances where they were utilized either before or after surgery.
-
Follow-Ups - Continuous monitoring is essential because of the possibility of recurrence and probable dissemination. This includes routine history taking, yearly testing for catecholamines in the blood and urine, and frequent cystoscopies. If symptoms or increased catecholamine levels are repeated, imaging studies such as CT (computed tomography) scans and 123I-MIBG scintiscan should be performed to find any signs of spreading to other locations.
What Is the Prognosis of Paraganglioma of the Urinary Bladder?
The prognosis is usually favorable for bladder paragangliomas that are confined. Continuous surveillance is still essential to detect any late recurrences, however long-lived. There is an increased risk of metastasis and recurrence in functional tumors due to factors such as expression of CgA (glycoprotein hormones, alpha polypeptide), numerous tumors, and advanced tumor stage (≥T3).
What Are the Indicators of Malignancy and Prognostic Factors in Bladder Paragangliomas?
Metastasis is a possible outcome in 15 percent to 20 percent of instances, and it is the most consistent indicator of malignant bladder paragangliomas. A worse prognosis may be indicated by characteristics such as vascular invasion, deeply invasive growth patterns, and numerous recurrences. Several variables, including younger age, larger tumor size, higher Ki67 proliferation rate, and kind of catecholamines generated, raise the likelihood that the tumor is malignant. For people with bladder paragangliomas, monitoring these parameters and taking metastasis into account is essential in assessing the likelihood of cancer and directing treatment in the future.
Conclusion
Paragangliomas of the urinary bladder are uncommon and provide special challenges for diagnosis and therapy. Despite being a rare condition, knowing its signs and symptoms and how to diagnose and treat it effectively are essential for providing the best possible care and results for those affected. For individuals with this rare bladder tumor, early identification and thorough treatment are essential for their good prognosis.
